AttaCH: A Phase 2, Multicenter, Long-Term, Open Label Extension Trial Evaluating Safety, Tolerability, and Efficacy of Subcutaneous Doses of TransCon CNP Administered Once Weekly in Children and Adolescents with Achondroplasia

Project: Clinical studiesClinical Study (Industry project)

Project Details

StatusActive
Effective start/end date06.12.202331.12.2030

Fields of science

  • 302035 Paediatrics and adolescent medicine